Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 2, pp. 315-332
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

The human microbiome in disease and pathology
Jim Manos
Apmis (2022) Vol. 130, Iss. 12, pp. 690-705
Open Access | Times Cited: 111
Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis
Júlio César Claudino dos Santos, Micael Porto Portela Lima, Gerly Anne de Castro Brito, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101812-101812
Closed Access | Times Cited: 52
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 45
The association between Parkinson’s disease and autoimmune diseases: A systematic review and meta-analysis
Mingqiang Li, Juan Wan, Zhenhong Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis
Nitish Kumar, Nalini Kanta Sahoo, Sidharth Mehan, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 71, pp. 104547-104547
Closed Access | Times Cited: 24
The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients
Hussein Sabit, Areej Kassab, Donia Alaa, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4080-4099
Open Access | Times Cited: 22
Blood-brain barrier biomarkers
Juan F. Zapata-Acevedo, Alejandra Mantilla-Galindo, Karina Vargas-Sánchez, et al.
Advances in clinical chemistry (2024), pp. 1-88
Closed Access | Times Cited: 9
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain
Mariarosaria Cuozzo, Vanessa Castelli, Carmen Avagliano, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 346-346
Open Access | Times Cited: 46
Mediterranean diet is associated with a lower probability of prodromal Parkinson's disease and risk for Parkinson's disease/dementia with Lewy bodies: A longitudinal study
Maria I. Maraki, Mary Yannakoulia, Georgia Xiromerisiou, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 4, pp. 934-942
Open Access | Times Cited: 17
Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson’s Disease
Elizabeth Riegelman, Kathy S. Xue, Jia-Sheng Wang, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2041-2041
Open Access | Times Cited: 7
Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review)
Qingchun Lei, Tingting Wu, Jin Wu, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 4
Open Access | Times Cited: 37
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 25, pp. 2802-2822
Open Access | Times Cited: 26
The pathobiological basis of depression in Parkinson disease: challenges and outlooks
K. A. Jellinger
Journal of Neural Transmission (2022) Vol. 129, Iss. 12, pp. 1397-1418
Open Access | Times Cited: 26
Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective
Siyu Dong, Miao‐Kun Sun, Chuan He, et al.
Brain Research Bulletin (2022) Vol. 183, pp. 84-93
Closed Access | Times Cited: 24
Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson’s Disease
Shobha Kumari, Rajeev Taliyan, Sunil Kumar Dubey
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 4, pp. 590-602
Closed Access | Times Cited: 15
The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease
Qing Li, Ling‐bing Meng, Lijun Chen, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 15
Inflammatory hallmarks in 6-OHDA- and LPS-induced Parkinson's disease in rats
Zhanna Oliynyk, Mariia Rudyk, Taisa Dovbynchuk, et al.
Brain Behavior & Immunity - Health (2023) Vol. 30, pp. 100616-100616
Open Access | Times Cited: 14
Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
Ikuko Miyazaki, Masato Asanuma
Antioxidants (2023) Vol. 12, Iss. 4, pp. 894-894
Open Access | Times Cited: 14
Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson’s disease in mice via modulating gut microbiota and short-chain fatty acids
Benchi Cai, Lifan Zhong, Qitong Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Unveiling the significance of synaptic proteins in parkinson's pathogenesis: A review
Ritu Soni, Jigna Shah
International Journal of Biological Macromolecules (2025), pp. 140789-140789
Closed Access
Autonomic dysfunction in neurodegenerative disease
Mara Mather
Nature reviews. Neuroscience (2025)
Closed Access
Non-dysbiotic gut microbiota profiles are associated with different spontaneous cortical activity in healthy older people
J. Ignacio Serrano, Silvia Cruz-Gil, C. Fernández, et al.
(2025)
Closed Access
Evidence for Peripheral Immune Activation in Parkinson’s Disease
Xueping Chen, Weihua Feng, Ruwei Ou, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 29
Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
Yongbo Kang, Xing Kang, Hongfang Zhang, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110162-175909142110162
Open Access | Times Cited: 29
Efficacy of acupuncture for the treatment of Parkinson’s disease-related constipation (PDC): A randomized controlled trial
Yingjia Li, IanI Leong, Jingqi Fan, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top